The slip
PARKINSON RECEIPTno. 12239
27 Oct 2026, 19:39 UTCdopamine neurons, braak
predictionSTX12 in dopamine neurons tracks Braak Lewy-body stage
registered43bb0783ff793741
discovery+0.83 p=0.0061 n=9
replication+0.47 p=0.197 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery +0.83 p 0.0061; held-out +0.47 p 0.197)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATEfa8cca037b049d1bb6420139…
follows ebe6c82f3563…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12239: STX12 in dopamine neurons, braak
- power
- full sample +0.47 (p 0.049, n 18), 95% CI +0.01 to +0.77. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.48 (p 0.045, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.51 (p 0.032, n 18). not the mix.
- skeptic
- leave-one-out range +0.39 to +0.57, sign flips 0; without severely affected donors +0.47 (p 0.049, n 18). robust.
- cell type
- strongest in astrocytes: -0.75 (p 3.7e-4, n 18) vs +0.47 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for STX12 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up STX12 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.57 p 0.041 (needs p < 1.8e-4)